Las Vegas Sands (NYSE: LVS) COO reports option exercises and stock sales

Rhea-AI Filing Summary

Las Vegas Sands Corp. reported that its President and Chief Operating Officer, who is also a director, exercised stock options and sold company shares. On December 1, 2025, he exercised options to acquire 210,305 shares of common stock at an exercise price of $52.53 per share and sold 210,305 shares at a weighted average price of $69.96, leaving 446,608 shares held directly afterward. On December 2, 2025, he exercised options for an additional 17,352 shares at $52.53 and sold 17,352 shares at a weighted average price of $68.97, again reporting 446,608 shares owned following the transactions.

The Form 4 notes that the options exercised on both days carried an exercise price of $52.53 and were scheduled to expire on March 28, 2026. After these moves, he continues to hold vested options to purchase 1,697,343 shares and 207,076 restricted stock units that remain unvested.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dumont Patrick

(Last) (First) (Middle)

5420 S. DURANGO DRIVE

(Street)

LAS VEGAS NV 89113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LAS VEGAS SANDS CORP [ LVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & COO

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		M		210,305	A	$52.53	656,913	D
Common Stock	12/01/2025		S		210,305	D	$69.96(1)	446,608	D
Common Stock	12/02/2025		M		17,352	A	$52.53	463,960	D
Common Stock	12/02/2025		S		17,352	D	$68.97(2)	446,608	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$52.53	12/01/2025		M			210,305	(3)	03/28/2026	Common Stock	210,305	$0	214,695	D
Option (Right to Buy)	$52.53	12/02/2025		M			17,352	(3)	03/28/2026	Common Stock	17,352	$0	197,343	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.75 to $70.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.75 to $69.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The options vested in five installments, as follows: 75,000 on December 31, 2016, 75,000 on December 31, 2017, 75,000 on December 31, 2018, 75,000 on December 31, 2019, and 350,000 on December 31, 2020.

Remarks:

In addition to the options exercised and the underlying shares sold on December 1, 2025 and December 2, 2025 (which as noted in Table II would have expired on March 28, 2026), Mr. Dumont holds options to purchase 1,697,343 shares that are vested and 207,076 restricted stock units that are unvested.

	/s/ Judy Tomkins, Attorney-in-Fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Las Vegas Sands (LVS) report on this Form 4?

The filing reports that the President & COO and director of Las Vegas Sands Corp. exercised stock options and sold common shares on December 1 and 2, 2025.

How many Las Vegas Sands (LVS) shares did the executive sell in this period?

On December 1, 2025, he sold 210,305 shares at a weighted average price of $69.96, and on December 2, 2025, he sold 17,352 shares at a weighted average price of $68.97.

What option exercises were reported for the Las Vegas Sands (LVS) executive?

He exercised options with a $52.53 exercise price to acquire 210,305 shares on December 1, 2025 and 17,352 shares on December 2, 2025, both relating to options expiring on March 28, 2026.

How many Las Vegas Sands (LVS) shares does the insider report owning after the transactions?

Following the reported transactions, he lists 446,608 shares of Las Vegas Sands common stock as beneficially owned directly.

What ongoing equity awards does the Las Vegas Sands (LVS) executive still hold?

He continues to hold vested options to purchase 1,697,343 shares and 207,076 restricted stock units that are unvested.

How were the Las Vegas Sands (LVS) sale prices determined in the Form 4?

The reported sale prices of $69.96 and $68.97 are weighted average prices from multiple trades within ranges disclosed in the footnotes.